The authors' reply to Allen et al.: "A Comment on Boyers et al.: 'eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal'".
作者信息
Boyers Dwayne, Jia Xueli, Jenkinson David, Mowatt Graham
出版信息
Pharmacoeconomics. 2013 Jan;31(1):91. doi: 10.1007/s40273-012-0005-6.
PMID:23329596
Abstract
摘要
Zotero 插件